Your partner in oncology

OTD : oncology therapeUtic development

OTD is a CRO focused solely on Oncology.

  • Specialized in the early development of single agent and combination regimens
  • Ensure rapid and efficient development of promising new cancer treatments
  • Offer preclinical and clinical consulting for VC groups or mid-size biotech companies
  • Optimize, launch and execute your clinical development plan
  • Support companies by providing strong medical input and oncology-experienced staff
  • Key partner with several small and mid-size companies
  • Design preclinical models to guide clinical development
  • Phase I/II study design and implementation to determine dose and schedule, and the feasibility and efficacy of your treatment


We are prepared to share our experience and support you in the development of studies that generate data in a timely, efficient and cost-effective manner.


Fsn0503h antibody-mediated blockade of cathepsin S as a therapeutic strategy for the treatment of solid tumors.


OTD - Oncology Therapeutic Development

100 rue Martre
92110 Clichy - FRANCE
Tel:  +33 1 47 15 01 01
Fax: +33 1 45 19 06 59

Contact Us